• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Renal denervation as an option for the management of hypertension

    2014-04-18 11:58:34GeorginaRadhiniSantiapillaiAlbertFerro
    THE JOURNAL OF BIOMEDICAL RESEARCH 2014年1期

    Georgina Radhini Santiapillai, Albert Ferro

    Department of Clinical Pharmacology, Cardiovascular Division, British Heart Foundation Centre of Research Excellence, King's College London, London, UK.

    Renal denervation as an option for the management of hypertension

    Georgina Radhini Santiapillai, Albert Ferro

    Department of Clinical Pharmacology, Cardiovascular Division, British Heart Foundation Centre of Research Excellence, King's College London, London, UK.

    Hypertension is a multifactorial condition which makes the development of treatment approaches difficult. The vast majority of patients are treated with lifestyle measures either alone or in combination with antihypertensive drugs, and this approach is largely successful in controlling blood pressure. However, for a subgroup of patients, control of blood pressure remains resistant to this approach and therefore the development of new strategies is imperative. The sympathetic nervous system has been known to be implicated in hypertension for many decades, and evidence from studies in the past has revealed the benefit of reducing sympathetic nerve activity in the control of blood pressure albeit with severe side effects. Recent technological advances have allowed for specific targeting of the renal sympathetic nerves by catheter ablation. The Symplicity HTN-1 and HTN-2 trials have provided strong evidence for renal denervation giving rise to considerable blood pressure reductions in treatment-resistant hypertensives and, due to the high incidence of hypertension worldwide, this carries the promise of further reducing the global burden of hypertension and its attendant complications. Here we review the evidence for renal denervation in the management of hypertension.

    hypertension, renal denervation, blood pressure

    INTRODUCTION

    Hypertension is a chronic condition which greatly increases the risk of developing cardiovascular disease, the leading cause of death worldwide as classified by the World Health Organisation (WHO)[1]. It is estimated that over a quarter of the world's adult population is hypertensive, and therefore therapeutic approaches that offer good control of blood pressure are of prime importance on a global scale[2].

    Hypertension is a major modifiable risk factor for cardiovascular disease[3]. It has been shown that a systolic blood pressure (SBP) increase of over 20 mmHg doubles the cardiovascular mortality risk, and that even small reductions in blood pressure significantly reduce the risk of cardiovascular events such as stroke[4,5]. First-line treatment involves advice about lifestyle changes, with subsequent pharmacological strategies being implemented if hypertension persists despite lifestyle measures. However, successful treatment of hypertension can be difficult to achieve in a significant minority of patients, who may fail to respond to antihypertensive medications of any class either alone or in combination.

    Resistant hypertension is defined as blood pressure above 140/90 mmHg in spite of the use of three or more antihypertensive agents, including a diuretic[6,7]. Essential hypertension has a multi-factorial aetiology which makes development of new therapeutic strategies a necessity, one novel approach being specific targeting of the sympathetic nervous system.

    Sympathetic nerves innervate, amongst others, organs involved in cardiovascular regulation; of particular relevance to hypertension is sympathetic innervations of the kidney[8]. It is well established that sympathetic nerves are involved in the development and maintenance of hypertension through increased sympathetic activity to the kidneys. Renal efferent and afferent nerves are situated inside the renal artery wall and perivascular soft tissue respectively[9]. Efferent nerve stimulation to the kidneys acts to increase blood pressure firstly by increased sodium reabsorption from the tubules, and secondly by increased renin secretion thereby activating the renin-angiotensin-aldosterone axis[10]. Chronic activation of renal afferents is found in certain disease states such as renal failure, which results in the kidneys being a source of sympathetic drive in the hypertension associated with renal failure (Fig. 1).

    The involvement of sympathetic nerve activation in the hypertensive state makes these nerves a rational therapeutic target. Before the advent of antihypertensive drugs, non-specific surgical methods to decrease sympathetic nerve activity were used as early as the 1920s to reduce blood pressure in patients with severe hypertension[11]. These attempts were extremely successful at lowering blood pressure in treated patients, however, the lack of specificity with such extensive denervation meant that there was high periprocedural morbidity and mortality. Selective renal sympathetic denervation, therefore, represents a more attractive therapeutic approach.

    Recent developments in device-based approaches to hypertension targeting the renal sympathetic system include a novel percutaneous catheter-based treatment. Here, radiofrequency energy is used to denervate sympathetic nerve fibres within the artery. The aim of this treatment is to selectively disrupt sympathetic nerve fibres without causing adverse effects in other organ systems[8]. Evidence from the Symplicity HTN-1 and HTN-2 trials in recent years has provided promising results which demonstrate significant and large decreases in blood pressure in patients withdrug-resistant hypertension. At present, however, there is insufficient evidence of long term benefit and the procedure has only been trialled in relatively small numbers of patients[12].

    Fig. 1 Renal afferent and efferent signalling from and to the kidney.

    PROCEDURE

    A catheter-based approach to renal sympathetic denervation has been developed. Early approaches involving the sympathetic nervous system in hypertension, as mentioned before, have highlighted the need for targeting the renal sympathetic nerves more specifically. From the radical sympathectomies and splanchnicectomies of the 1920s, to the marginally more successful targeted removal of renal sympathetic ganglia by Grimson et al.[13], there have been several attempts at attenuating sympathetic nerve activity in the context of blood pressure[8]. These measures have demonstrated the effectiveness of therapies that reduce sympathetic nerve activity on long-term blood pressure control, but equally highlight the need for more specific methods without the side effects of previous approaches.

    A minimally invasive, endovascular catheterbased procedure aims to disrupt neurogenic reflexes involved in the control of blood pressure using radiofrequency (RF) energy[12]. The rationale for this targeted treatment is based firstly on the fact that since the kidneys are retroperitoneal organs, direct access to the nerves is difficult, secondly, the fact that the renal efferent and afferent nerves are in close proximity to the renal artery wall, allowing for greater susceptibility to RF energy if approached by the endovascular route. In a human post-mortem histological study, Atherton et al.[9]used sections from human renal arteries and measured the distance of nerves from the lumen-intima interface. It was found that over 90% of renal sympathetic nerves resided within 2 mm of the renal artery lumen; considering the RF penetration depth of a cardiac ablation catheter is up to 9.5 mm[14], a catheter-based RF approach in specifically targeting renal sympathetic nerves is likely to be feasible.

    Before introducing the catheter, angiography is used to determine renal anatomic eligibility for the procedure, to exclude any renal artery stenosis or other abnormality of renal artery anatomy. The procedure is carried out under local anesthesia, whereby the catheter is inserted through the femoral artery and guided into each renal artery under fluoroscopic control. A generator delivers low-power RF ablations within each ‘renal artery at 4-6 points along its length, in a spiral pattern’[12]. Ablations last two minutes each and are spaced both longitudinally and rotationally along the course of the renal artery (Fig. 2). A predetermined algorithm allows for automatic generation of RF energy and careful monitoring throughout the procedure of temperature and impedance.

    PRECLINICAL EVIDENCE

    Preclinical experiments that have used renal denervation therapeutically have used a variety of animal models in which to assess renal sympathetic nerve contribution to systemic organ function. One study by Kassab et al. assessed the effect of renal sympathetic nerve ablation on blood pressure using a canine model of obesity-induced hypertension[15]. Obesity is commonly observed in hypertensive patients and therefore is a good model to study the effect of a novel blood pressure-lowering strategy.

    In this study, two groups were evaluated: a control group and a bilaterally renal-denervated group. Both groups were, after a control period, fed a highfat diet, which resulted in a rise in body weight in the two groups by 50%. The study found that, with the high-fat diet, there was a significant increase in blood pressure in the control dogs (from 95 ± 2 to 109 ± 4 mmHg) but no significant change in blood pressure in the denervated dogs (87 ± 3 to 90 ± 4 mmHg). Another endpoint of this study looked at the effect of renal denervation on sodium retention, which is thought to be increased with efferent nerve stimulation. In the denervated dogs, cumulative sodium retention was approximately 50% less than in the controls (control: 445 ± 85 mmol, denervated: 252 ± 47 mmol). The findings from this study support the theory that renal sympathetic activity is involved in mediating hypertension and sodium retention associated with obesity. This is concordant with other renal denervation preclinical studies, that have similarly shown attenuation of hypertension in other animal models[16].

    Of relevance to the catheter-based approach, a study by Rippy et al.[17]used a healthy swine model. Here they tested the vascular safety and healing response of RF ablations given via the Symplicity Catheter System. Angiography and histological analyses were carried out before the procedure and at 6 months post-ablation, assessing for any perfusion defects and vascular damage respectively. The study found that catheter-based denervation could selectively ablate the renal nerves without causing any clinically significant damage to the renal artery wall or other renal pathology, suggesting the catheter system to have a good safety profile and paving the way for proof-of-principle and randomized controlled trials in humans.

    Fig. 2 Schematic representation of catheter placement and ablation sites.

    CLINICAL TRIALS

    Proof-of-principle study

    In recent years, several clinical trials have been published that provide good evidence for renal denervation having an antihypertensive effect. The first proof-of-principle cohort study was carried out by Krum and colleagues[18]with the aim of evaluating the safety and blood pressure-lowering efficacy of specific renal nerve denervation. In the Symplicity HTN-1 study, 45 patients with treatment-resistant hypertension underwent renal sympathetic nerve ablation using a catheter-based approach (Symplicity by Ardian Inc. Palo Alto, CA, USA). Treatment-resistant hypertension was defined as baseline SBP≥160 mmHg despite use of three or more antihypertensive drugs. Patients had a mean age of 58 ± 9 years, average blood pressure of 177/101 ± 20/15 mmHg and were using an average of 4.7 ± 1.5 antihypertensive medications. The procedure itself was noted to cause visceral abdominal pain that was present only during the procedure on application of RF energy; this was managed with intravenous narcotics and sedatives. The median procedure time was 38 min.

    Short term follow-up angiography 14-30 days after the procedure and magnetic resonance (MR) angiography at 6 months showed a good vascular safety profile with no adverse clinical events related to the treatment, nor was any alteration in renal function noted. There was a significant decrease in blood pressure (systolic: 20-25 mmHg; diastolic: 10-15 mmHg) which persisted throughout the one year follow-up period (Table 1).

    In agreement with the reductions in blood pressure seen after treatment, a decrease in efferent sympathetic activity was shown in terms of noradrenaline release from the kidneys (measured as spillover of noradrenaline into the circulation). In the subgroup of 10 patients who underwent this test, there was a mean decrease in noradrenaline spillover of 47% (95% CI, 28-65%). This demonstrates the efficacy of the catheter-based device in achieving efferent sympathetic denervation[18].

    Independent review of angiograms and serious adverse events reduced the possibility of bias in data analysis. However, as the study was non-blinded and did not have a control group, due to the study being proof-of-concept, a placebo effect may have played a part. A serious limitation to this study is the selection of the trial population. Eligible patients were those who had resistant hypertension; however, resistant hypertension is a multifactorial condition which encompasses several causes including white coat hypertension, secondary hypertension and poor adherence to medication[6]. These are factors that were not evaluated and accounted for within the study. In addition, at the 9- and 12- month follow-up points, there was a considerable attrition of patients available for followup, as shown in Table 1. Overall, however, the studyprovides promising support for the effectiveness of renal sympathetic ablation as a strategy in the management of resistant hypertension.

    Table 1 Effect of renal denervation on blood pressure as a function of time

    Expanded cohort study

    Two year follow-up evidence from the original study reaffirmed the notion that catheter-based renal denervation contributes to a long-term substantial decrease in blood pressure[19]. The expanded cohort study assessed the durability of the blood pressurelowering effect, of importance due to sympathetic efferents having previously been shown to regrow after nerve injury[20]. In this expanded cohort study, 153 patients with the same inclusion criteria were treated by the same approach used in the initial cohort study[19]. It was found that the initial blood pressure reduction seen post-procedure in the initial study continued out to 24 months on follow-up. Over 90% of patients had an office blood pressure reduction of over 10 mmHg, averaging 32/14 mmHg at 24 months. This is of relevance when considering that the patient population was previously unresponsive to three or more hypertensive medications, further supporting the findings from the initial trial.

    Symplicity HTN-2

    The Symplicity HTN-2 randomized control trial[21]built upon the impressive findings from the proof-ofprinciple study. This study sought to further clarify the effectiveness and safety of catheter-based treatment of resistant hypertension. One hundred and six patients with treatment-resistant hypertension were enrolled. Similar inclusion criteria to the initial cohort study were used, with the additional inclusion of patients with type 2 diabetes who had a baseline SBP of≥ 150 mmHg and fulfilled the additional criteria specified. Patients were then randomized to renal sympathetic denervation (n = 52) or control (n = 54) groups and followed up over a period of 6 months.

    At 6 months post-procedure, office blood pressure measurements in the renal denervation group were decreased significantly, by 32/12 mmHg (SD 23/11, baseline mean blood pressure 178/96 mmHg; P < 0.0001), in comparison to no significant change in blood pressure observed in the control group. The difference in the primary endpoint of seated office blood pressure between the groups at 6 months was significant at 33/11 mmHg (P < 0.0001 for both SBP and DBP). Additionally, in a subgroup of patients where home and ambulatory blood pressure were measured, similar findings were observed. From baseline values, the renal denervation group (n = 20) had a decrease from baseline values for mean systolic and diastolic blood pressure of 11/7 mmHg (SD 15/11; P = 0.006 for SBP and P = 0.014 for DBP change) whereas there was no significant change in the control group (n = 25)[21]. Furthermore, no adverse clinical events related to the procedure were seen, which substantiates earlier trial evidence about the good safety profile of this technique.

    Since this was a randomized controlled trial, this largely answers the potential criticisms above of a possible placebo effect and selection bias that could affect the validity of the results. Having said that, the control group did not undergo a sham operation; therefore, the trial was not double-blinded, so that some possibility of bias remains. Currently, a multicentre, double-blinded, randomized controlled trial (Symplicity HTN-3) is ongoing, evaluating the procedure in a larger group of patients.

    The results of the Symplicity HTN-2 study provide strong evidence to support previous findings that renal denervation is a suitable and effective option in the management of treatment-resistant essential hypertension. The data are encouraging based on good efficacy in blood pressure control and good safety profile.

    Future Prospects

    Renal denervation by catheter ablation has been shown to have promising results in the Symplicity clinical trials. However, the exact pathophysiological mechanism by which denervation causes blood pressure reduction is yet to be elucidated precisely. Radiotracer dilution methods measuring noradrenaline sp-illover, as used in the proof-of-principle study above, have demonstrated reduced nordadrenaline spillover post-renal denervation, suggesting that the procedure may lower blood pressure by reducing efferent renal sympathetic nerve stimulation[8]. But whether a decrease in adrenergic activity occurs before blood pressure reduction remains to be determined.

    Sympathetic reinnervation is important to consider in assessing the long-term durability of renal nerve denervation and its blood pressure-lowering effects. There is a possibility that sympathetic nerves can regrow after damage. The evidence for good long-term efficacy in the two year follow-up study suggests that, despite the possibility of regrowth and reinnervation, this appears not to affect the blood pressure-lowering effect of the procedure[19]. However, it would be useful to further clarify whether sympathetic reinnervation of the kidney occurs and whether this has an effect on blood pressure control[22]. This requires a longer follow-up period and an increased understanding of the process of reinnervation in the human kidney.

    Importantly, clinical trials assessing renal denervation have been restricted to a specific group of patients with treatment-resistant essential hypertension. The clinical studies thus far have shown good efficacy and safety in these patients, but to further investigate the therapeutic benefit of renal denervation other subgroups of hypertensives need to be evaluated. These could include those that have milder forms of essential hypertension and in patients that have hypertension secondary to disease states such as renal impairment; in the future, it may be useful to examine whether renal denervation is appropriate in the earlier stages of hypertension as a preventative measure[23].

    An additional consideration is that renal denervation has been examined thus far using RF catheter-based ablation. Other methods for achieving renal denervation using methods such as ultrasound, microwaves, lasers and robotic surgery may be useful to trial also.

    CONCLUSION

    Rrenal denervation is a potentially useful treatment modality in patients whose hypertension is refractory to conventional hypertension therapies. Targeting sympathetic nerves to reduce blood pressure is an old concept that has been brought to the fore of novel antihypertensive therapies with the development of sophisticated devices that have specificity in their application. The promising results from catheter-based renal sympathetic denervation have offered new prospects, specifically in the treatment of resistant essential hypertension. Both the HTN-1 and HTN-2 studies demonstrated the good safety profile and efficacy in reducing blood pressure using catheter nerve ablation. The UK National Institute for Health and Clinical Excellence has recently published guidelines for its use in suitably chosen patients with resistant hypertension[12].

    Catheter-based treatment is still in the early stages of clinical research, and larger and longer-term follow-up trials will be needed to properly assess the durability of blood pressure reduction as well as longterm safety.

    [1] World Health Organisation. The top 10 causes of death. 2011; Available at: http://www.who.int/mediacentre/ factsheets/fs310/en/index.html. (accessed 12/05, 2012).

    [2] Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23.

    [3] Poulter N. Global risk of cardiovascular disease. Heart 2003; 89(S2): ii2-ii5.

    [4] Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682-86.

    [5] Mancia G. Blood pressure reduction and cardiovascular outcomes: past, present, and future. Am J Cardiol 2007; 100 (S): 3J-9J.

    [6] Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: e510-26.

    [7] Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 2008; 52: 1749-57.

    [8] Schlaich MP, Krum H, Sobotka PA, Esler MD. Renal denervation and hypertension. Am J Hypertens 2011; 24: 635-42.

    [9] Atherton DS, Deep NL, Mendelsohn FO. Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat 2012; 25: 628-33.

    [10] DiBona GF. Neural control of the kidney: past, present, and future. Hypertension 2003; 41: 621-4.

    [11] Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet 1953; 1: 403-8.

    [12] National Institute for Health and Clinical Excellence. Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension. 2012; Available at: http://guidance.nice.org.uk/ipg418. (accessed 11/19, 2012).

    [13] Grimson KS. Total Thoracic and partial to total lumbar sympathectomy and celiac ganglionectomy in the treatment of hypertension. Ann Surg 1941; 114: 753-75.

    [14] Holmes D, Fish JM, Byrd IA, Dando JD, Fowler SJ,Cao H, et al. Contact sensing provides a highly accurate means to titrate radiofrequency ablation lesion depth. J Cardiovasc Electrophysiol 2011; 22: 684-90.

    [15] Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25: 893-7.

    [16] Ye S, Zhong H, Yanamadala V, Campese VM. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens 2002; 15: 717-24.

    [17] Rippy MK, Zarins D, Barman NC, Wu A, Duncan KL, Zarins CK. Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol 2011; 100: 1095-1101.

    [18] Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275-81.

    [19] Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011; 57: 911-7.

    [20] Kaye DM, Esler M, Kingwell B, McPherson G, Esmore D, Jennings G. Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. Circulation 1993; 88: 1110-8.

    [21] Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, et al. Renal sympathetic denervation in patients with treatmentresistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903-9.

    [22] Grassi G, Mancia G. New therapeutic approaches for resistant hypertension. J Nephrol 2012; 25: 276-81.

    [23] Doumas M, Douma S. Renal sympathetic denervation: the jury is still out. Lancet 2010; 376: 1878-80.

    Received 23 March 2013, Revised 16 April 2013, Accepted 02 May 2013, Epub 02 June 2013

    The authors reported no conflict of interests.

    10.7555/JBR.27.20130036

    欧美精品一区二区免费开放| 日韩亚洲欧美综合| 国产亚洲精品久久久com| 狂野欧美激情性bbbbbb| 青春草视频在线免费观看| 五月开心婷婷网| 亚洲精品视频女| 亚洲国产精品专区欧美| 美女内射精品一级片tv| 如何舔出高潮| av视频免费观看在线观看| 精品酒店卫生间| 久久99蜜桃精品久久| av一本久久久久| av不卡在线播放| 日日啪夜夜爽| 秋霞伦理黄片| 赤兔流量卡办理| 午夜精品国产一区二区电影| 亚洲四区av| 王馨瑶露胸无遮挡在线观看| 亚洲国产最新在线播放| 青青草视频在线视频观看| 国产精品欧美亚洲77777| 自拍欧美九色日韩亚洲蝌蚪91 | 国产精品一区www在线观看| 精品一区在线观看国产| 国产精品一区二区性色av| 国产淫语在线视频| 国产乱人偷精品视频| 久久国产亚洲av麻豆专区| 国产伦精品一区二区三区视频9| 99re6热这里在线精品视频| 如何舔出高潮| 乱系列少妇在线播放| 亚洲精品第二区| 在线免费十八禁| 插阴视频在线观看视频| 国产精品99久久99久久久不卡 | 国产精品熟女久久久久浪| 黄片wwwwww| av免费观看日本| 七月丁香在线播放| 亚洲精品乱久久久久久| 久久久久视频综合| 亚洲av电影在线观看一区二区三区| 激情五月婷婷亚洲| 欧美国产精品一级二级三级 | 少妇人妻精品综合一区二区| 国产av一区二区精品久久 | 91精品国产国语对白视频| 如何舔出高潮| 国产在线免费精品| 亚洲国产精品专区欧美| av不卡在线播放| 少妇精品久久久久久久| 午夜福利网站1000一区二区三区| 国产精品三级大全| 99热全是精品| 蜜桃在线观看..| 亚洲欧美精品自产自拍| 有码 亚洲区| 黄色视频在线播放观看不卡| 久久亚洲国产成人精品v| 亚洲真实伦在线观看| 色哟哟·www| 久久久久精品性色| 亚洲国产精品999| 国产亚洲5aaaaa淫片| 国产成人精品婷婷| 毛片一级片免费看久久久久| av免费在线看不卡| 夜夜爽夜夜爽视频| 高清毛片免费看| 久久久久久久亚洲中文字幕| 另类亚洲欧美激情| 老司机影院毛片| 精品熟女少妇av免费看| 国产一区二区在线观看日韩| 97在线视频观看| 深爱激情五月婷婷| 在现免费观看毛片| 精品一区二区三区视频在线| 大香蕉97超碰在线| 99久国产av精品国产电影| 男人狂女人下面高潮的视频| 国产欧美亚洲国产| 国产精品秋霞免费鲁丝片| 亚洲婷婷狠狠爱综合网| 国产成人精品一,二区| 成人毛片60女人毛片免费| 国产精品三级大全| 乱系列少妇在线播放| 一级爰片在线观看| 在线观看人妻少妇| 亚洲怡红院男人天堂| 国产黄频视频在线观看| 久久精品人妻少妇| 久久99精品国语久久久| 午夜福利在线在线| 最黄视频免费看| 色吧在线观看| 久久综合国产亚洲精品| 一区二区三区乱码不卡18| 麻豆精品久久久久久蜜桃| 亚洲人与动物交配视频| 狂野欧美白嫩少妇大欣赏| 国产69精品久久久久777片| 国产久久久一区二区三区| 亚洲不卡免费看| 欧美变态另类bdsm刘玥| 亚洲av二区三区四区| 婷婷色综合大香蕉| 国产伦精品一区二区三区视频9| 观看av在线不卡| 高清日韩中文字幕在线| 国产精品一区二区在线不卡| 午夜免费鲁丝| 国产 精品1| 特大巨黑吊av在线直播| 人人妻人人看人人澡| 黄色配什么色好看| 在线观看免费日韩欧美大片 | 在现免费观看毛片| 国产乱来视频区| 男人狂女人下面高潮的视频| 涩涩av久久男人的天堂| 国产精品一区二区三区四区免费观看| av福利片在线观看| 欧美精品人与动牲交sv欧美| av在线观看视频网站免费| 最黄视频免费看| 精品国产乱码久久久久久小说| 又大又黄又爽视频免费| 日本wwww免费看| 国产精品免费大片| av卡一久久| 干丝袜人妻中文字幕| 国产精品蜜桃在线观看| 国产一区有黄有色的免费视频| 成人免费观看视频高清| 亚洲熟女精品中文字幕| 我要看日韩黄色一级片| 亚洲欧美日韩卡通动漫| 日日摸夜夜添夜夜爱| 能在线免费看毛片的网站| 一本一本综合久久| 一级片'在线观看视频| 男女啪啪激烈高潮av片| 寂寞人妻少妇视频99o| 亚洲电影在线观看av| 亚洲第一区二区三区不卡| 最近中文字幕2019免费版| 日本-黄色视频高清免费观看| 色综合色国产| av福利片在线观看| 成人毛片60女人毛片免费| 日韩人妻高清精品专区| 只有这里有精品99| 亚洲熟女精品中文字幕| av一本久久久久| 欧美一区二区亚洲| 六月丁香七月| 国产精品久久久久久精品电影小说 | 激情 狠狠 欧美| 国产高清有码在线观看视频| 美女cb高潮喷水在线观看| 女性被躁到高潮视频| 99热6这里只有精品| 韩国高清视频一区二区三区| 亚洲精品国产av蜜桃| 国产又色又爽无遮挡免| 菩萨蛮人人尽说江南好唐韦庄| 日韩亚洲欧美综合| 伦理电影大哥的女人| 啦啦啦在线观看免费高清www| 韩国av在线不卡| 色综合色国产| 高清av免费在线| 美女视频免费永久观看网站| 国产高潮美女av| 超碰av人人做人人爽久久| 99久久人妻综合| 午夜福利网站1000一区二区三区| 免费观看无遮挡的男女| 亚洲精华国产精华液的使用体验| 亚洲一级一片aⅴ在线观看| 国产精品一区www在线观看| 亚洲国产日韩一区二区| 免费久久久久久久精品成人欧美视频 | 午夜视频国产福利| 菩萨蛮人人尽说江南好唐韦庄| 精品人妻熟女av久视频| 岛国毛片在线播放| 男女国产视频网站| videos熟女内射| 国产极品天堂在线| 国产精品久久久久成人av| 欧美高清成人免费视频www| 国产精品秋霞免费鲁丝片| 黄色视频在线播放观看不卡| 九九在线视频观看精品| 观看美女的网站| 又黄又爽又刺激的免费视频.| 黄色日韩在线| 亚洲欧美精品专区久久| 一本色道久久久久久精品综合| 国精品久久久久久国模美| 亚洲国产成人一精品久久久| 亚洲中文av在线| 一区二区av电影网| 六月丁香七月| 久久精品国产亚洲网站| a级一级毛片免费在线观看| 国产精品福利在线免费观看| 国产黄片视频在线免费观看| av线在线观看网站| 国产黄片美女视频| 3wmmmm亚洲av在线观看| 久久国产亚洲av麻豆专区| videos熟女内射| 男女免费视频国产| 亚洲国产欧美在线一区| 秋霞在线观看毛片| 岛国毛片在线播放| av免费在线看不卡| 老司机影院成人| 国产色爽女视频免费观看| av网站免费在线观看视频| 97在线视频观看| 免费在线观看成人毛片| 国产成人freesex在线| 成人国产麻豆网| 少妇猛男粗大的猛烈进出视频| 亚洲精品一区蜜桃| 成人亚洲欧美一区二区av| 精品午夜福利在线看| 久久久久国产精品人妻一区二区| 亚洲最大成人中文| 99热网站在线观看| 免费观看的影片在线观看| 在线观看免费视频网站a站| 亚洲av中文av极速乱| 国产黄片视频在线免费观看| 亚洲精品456在线播放app| 欧美人与善性xxx| 成人国产麻豆网| 国产亚洲精品久久久com| 国产成人午夜福利电影在线观看| 哪个播放器可以免费观看大片| 天天躁日日操中文字幕| 乱码一卡2卡4卡精品| 纵有疾风起免费观看全集完整版| 中国国产av一级| 亚洲av不卡在线观看| 国产在线视频一区二区| 久久精品久久久久久噜噜老黄| 最后的刺客免费高清国语| 国产淫语在线视频| 亚洲熟女精品中文字幕| 大香蕉97超碰在线| 中国美白少妇内射xxxbb| 观看av在线不卡| 97热精品久久久久久| 国产色婷婷99| 天天躁夜夜躁狠狠久久av| 日韩强制内射视频| 国产精品久久久久久久久免| 九九在线视频观看精品| 国产亚洲午夜精品一区二区久久| 99热这里只有是精品在线观看| 国产精品.久久久| 亚洲欧美成人综合另类久久久| 国语对白做爰xxxⅹ性视频网站| 日日啪夜夜爽| 国产高潮美女av| 日本爱情动作片www.在线观看| 嘟嘟电影网在线观看| 色综合色国产| 综合色丁香网| 亚洲成人手机| 欧美高清性xxxxhd video| 日本免费在线观看一区| 色吧在线观看| 久久久久网色| 免费人成在线观看视频色| 日韩人妻高清精品专区| 国产视频首页在线观看| 亚洲国产成人一精品久久久| 日本黄色日本黄色录像| 国产精品无大码| 一级毛片电影观看| 狂野欧美激情性bbbbbb| av在线app专区| 22中文网久久字幕| 女人十人毛片免费观看3o分钟| 老熟女久久久| 国产免费一级a男人的天堂| 舔av片在线| 久久精品夜色国产| 久久av网站| 久久精品国产自在天天线| 18禁在线无遮挡免费观看视频| 久久久久久久国产电影| 免费看光身美女| 亚洲天堂av无毛| 天堂8中文在线网| 一本一本综合久久| 又黄又爽又刺激的免费视频.| 老司机影院毛片| 日韩精品有码人妻一区| 亚洲精品国产色婷婷电影| 免费观看性生交大片5| 国产乱来视频区| 久热这里只有精品99| freevideosex欧美| 一级片'在线观看视频| 久久国内精品自在自线图片| 在线观看人妻少妇| 精品国产一区二区三区久久久樱花 | 天堂中文最新版在线下载| 欧美国产精品一级二级三级 | 国产在线一区二区三区精| 老司机影院毛片| 日韩不卡一区二区三区视频在线| av国产久精品久网站免费入址| 国产久久久一区二区三区| 大话2 男鬼变身卡| 搡老乐熟女国产| 久久精品久久久久久久性| 国产av码专区亚洲av| 亚洲国产精品一区三区| 欧美极品一区二区三区四区| 国产伦在线观看视频一区| 成人黄色视频免费在线看| 在线观看美女被高潮喷水网站| 精品一区二区三区视频在线| 成人综合一区亚洲| 国产精品偷伦视频观看了| 久久6这里有精品| 国产一区有黄有色的免费视频| 亚洲欧美一区二区三区黑人 | 成人免费观看视频高清| 国产精品一及| 免费看av在线观看网站| av福利片在线观看| 亚洲精品国产色婷婷电影| 在线 av 中文字幕| 国产av一区二区精品久久 | 精品久久国产蜜桃| 蜜桃亚洲精品一区二区三区| 久久国产精品大桥未久av | 中国国产av一级| 亚洲精品一区蜜桃| 日本黄大片高清| 免费久久久久久久精品成人欧美视频 | 亚洲欧美日韩东京热| 少妇人妻 视频| 欧美日韩国产mv在线观看视频 | 午夜激情久久久久久久| 麻豆精品久久久久久蜜桃| 久久久久久久久久久免费av| 亚洲一级一片aⅴ在线观看| 人妻系列 视频| 欧美区成人在线视频| 欧美精品国产亚洲| 蜜桃亚洲精品一区二区三区| 欧美xxⅹ黑人| 日韩中文字幕视频在线看片 | 国产黄频视频在线观看| 毛片一级片免费看久久久久| 99热这里只有是精品50| 高清日韩中文字幕在线| 免费少妇av软件| av又黄又爽大尺度在线免费看| 少妇精品久久久久久久| 亚洲内射少妇av| 国产伦精品一区二区三区四那| 色哟哟·www| 国产在线男女| a级毛片免费高清观看在线播放| 久久这里有精品视频免费| 黑人猛操日本美女一级片| 国产在线男女| 成人18禁高潮啪啪吃奶动态图 | 一级av片app| 国产一区二区三区av在线| 免费看日本二区| 亚洲欧美日韩无卡精品| 九九爱精品视频在线观看| 精品一区二区免费观看| 免费黄频网站在线观看国产| 九色成人免费人妻av| a级一级毛片免费在线观看| a级毛片免费高清观看在线播放| 18+在线观看网站| 18禁在线播放成人免费| 国产一区二区三区综合在线观看 | 欧美xxⅹ黑人| 丝袜脚勾引网站| 亚洲精品日韩在线中文字幕| 亚洲精品456在线播放app| 久久精品国产自在天天线| 熟妇人妻不卡中文字幕| 亚洲av.av天堂| 亚洲第一av免费看| 91久久精品国产一区二区三区| 亚洲人成网站在线观看播放| 国产精品女同一区二区软件| 性高湖久久久久久久久免费观看| 美女cb高潮喷水在线观看| 人妻夜夜爽99麻豆av| 亚洲人与动物交配视频| 国产 一区精品| 成年av动漫网址| 国内揄拍国产精品人妻在线| 中文字幕人妻熟人妻熟丝袜美| 亚州av有码| 国产无遮挡羞羞视频在线观看| 街头女战士在线观看网站| 国产一级毛片在线| 菩萨蛮人人尽说江南好唐韦庄| 国产色爽女视频免费观看| 国产亚洲欧美精品永久| 欧美高清成人免费视频www| 色视频在线一区二区三区| 女人久久www免费人成看片| 亚洲高清免费不卡视频| 午夜福利在线观看免费完整高清在| 热99国产精品久久久久久7| 在线观看av片永久免费下载| 成人二区视频| 99久久精品热视频| 男人添女人高潮全过程视频| 激情五月婷婷亚洲| 岛国毛片在线播放| 毛片女人毛片| 亚洲av中文av极速乱| 国产精品伦人一区二区| 一区二区av电影网| 精品一区二区三卡| 久久综合国产亚洲精品| av福利片在线观看| 下体分泌物呈黄色| 久久国产乱子免费精品| 精品亚洲成a人片在线观看 | www.av在线官网国产| 97热精品久久久久久| 我的老师免费观看完整版| 免费在线观看成人毛片| 视频区图区小说| 又黄又爽又刺激的免费视频.| 国产亚洲午夜精品一区二区久久| 精品少妇黑人巨大在线播放| 18禁裸乳无遮挡免费网站照片| 国产av精品麻豆| 大片免费播放器 马上看| 亚洲在久久综合| 国产国拍精品亚洲av在线观看| 欧美 日韩 精品 国产| 国产永久视频网站| 91在线精品国自产拍蜜月| 久久这里有精品视频免费| 亚洲国产精品专区欧美| 免费看日本二区| 婷婷色麻豆天堂久久| 男人和女人高潮做爰伦理| 网址你懂的国产日韩在线| 中国国产av一级| 亚洲三级黄色毛片| 18禁裸乳无遮挡动漫免费视频| 97在线人人人人妻| 日本vs欧美在线观看视频 | 中文资源天堂在线| 91精品伊人久久大香线蕉| 欧美日韩一区二区视频在线观看视频在线| 少妇 在线观看| 少妇被粗大猛烈的视频| 少妇精品久久久久久久| 青春草亚洲视频在线观看| 三级经典国产精品| 人妻少妇偷人精品九色| 精品人妻视频免费看| videos熟女内射| 一级毛片电影观看| 三级经典国产精品| 乱系列少妇在线播放| 亚洲成人中文字幕在线播放| 亚洲av成人精品一区久久| 在线观看国产h片| 色综合色国产| 下体分泌物呈黄色| 最黄视频免费看| 国产日韩欧美在线精品| 久久综合国产亚洲精品| 国产有黄有色有爽视频| 国产视频内射| 九九久久精品国产亚洲av麻豆| 亚洲丝袜综合中文字幕| 91在线精品国自产拍蜜月| 精品熟女少妇av免费看| 欧美3d第一页| 日韩三级伦理在线观看| 亚洲,欧美,日韩| 能在线免费看毛片的网站| 91午夜精品亚洲一区二区三区| 亚洲av不卡在线观看| 中文精品一卡2卡3卡4更新| 久久亚洲国产成人精品v| 王馨瑶露胸无遮挡在线观看| 亚洲激情五月婷婷啪啪| av线在线观看网站| 亚洲精品国产成人久久av| 女性生殖器流出的白浆| 男人爽女人下面视频在线观看| 国产一区二区三区av在线| 又黄又爽又刺激的免费视频.| 成人漫画全彩无遮挡| .国产精品久久| 欧美xxxx性猛交bbbb| 久久精品久久久久久噜噜老黄| 男女无遮挡免费网站观看| 国产高清有码在线观看视频| 永久免费av网站大全| 如何舔出高潮| 亚洲内射少妇av| 看免费成人av毛片| 国产人妻一区二区三区在| 日韩伦理黄色片| 成人一区二区视频在线观看| 久久99热这里只频精品6学生| 亚洲欧美一区二区三区黑人 | 久久久久久久久久久免费av| 狂野欧美激情性bbbbbb| 精品久久久久久电影网| 91精品一卡2卡3卡4卡| 一区二区三区乱码不卡18| 亚洲精品,欧美精品| 老女人水多毛片| 一级毛片久久久久久久久女| 永久网站在线| 国产精品蜜桃在线观看| 免费久久久久久久精品成人欧美视频 | 少妇人妻一区二区三区视频| 丝袜喷水一区| 亚洲精品久久午夜乱码| 国产高潮美女av| 久久久久久人妻| 午夜激情久久久久久久| 少妇高潮的动态图| 少妇人妻精品综合一区二区| www.色视频.com| 久久亚洲国产成人精品v| 婷婷色综合www| 少妇人妻一区二区三区视频| 青春草视频在线免费观看| 国产成人免费无遮挡视频| 亚洲激情五月婷婷啪啪| 精品亚洲成a人片在线观看 | 你懂的网址亚洲精品在线观看| 干丝袜人妻中文字幕| 国产亚洲91精品色在线| 成人免费观看视频高清| 少妇熟女欧美另类| 亚州av有码| 成人高潮视频无遮挡免费网站| 熟女人妻精品中文字幕| 国产成人91sexporn| 亚洲性久久影院| 在线 av 中文字幕| 亚洲av成人精品一二三区| 午夜免费男女啪啪视频观看| 一区二区三区乱码不卡18| 国产真实伦视频高清在线观看| 国产成人精品一,二区| 高清不卡的av网站| 91午夜精品亚洲一区二区三区| 中文字幕人妻熟人妻熟丝袜美| 在线观看美女被高潮喷水网站| 国产精品一区二区性色av| 内地一区二区视频在线| 日韩强制内射视频| 久久人妻熟女aⅴ| 午夜精品国产一区二区电影| 久久ye,这里只有精品| 一级毛片黄色毛片免费观看视频| 在线免费观看不下载黄p国产| 中国三级夫妇交换| 一个人看视频在线观看www免费| 国产 精品1| 国产成人免费观看mmmm| 亚洲在久久综合| 日韩 亚洲 欧美在线| 精品一区二区免费观看| 亚洲在久久综合| 最近2019中文字幕mv第一页| 99热网站在线观看| 国产成人freesex在线| 97精品久久久久久久久久精品| 色吧在线观看| 九草在线视频观看| 韩国av在线不卡| 国产亚洲91精品色在线| av福利片在线观看| 国产精品伦人一区二区| 免费av中文字幕在线| 免费观看av网站的网址| 熟妇人妻不卡中文字幕| 深爱激情五月婷婷| 中文天堂在线官网| 国产乱人偷精品视频| 日本爱情动作片www.在线观看| 日韩av在线免费看完整版不卡| 国产高清三级在线| 毛片一级片免费看久久久久|